Trasylol Heart Attacks & Stroke Injury Studies Trigger FDA Evaluation
Recent published Trasylol studies have reported an increased risk of heart attack, kidney failure and stroke in open heart surgery patients treated with aprotinin. The FDA is conducting a safety review of Trasylol and has published recommendations to healthcare providers.
Aprotinin (Trasylol) is used during cardiac surgery to help reduce bleeding in high-risk patients. The risk of suffering a stroke is 181 percent greater for patients taking Trasylol, compared to those taking generic alternatives or no medication at all, a recent study has discovered. Aprotinin stroke is just one of the serious and life-threatening risks disclosed in a January 2006 study appearing in the New England Journal of Medicine. Researchers have found that aprotinin increases risk of heart attack by 55% and results in a 181% increased risk of stroke or encephalopathy.
The medical researcher, Dr. Dennis Mangano, estimates that 22,000 patient lives could have been saved if Trasylol had been removed from the market when his January 2006 study was first published. Given that there are much safer and less expensive alternative heart surgery drugs one has to question the potential risk that patients were exposed to during their surgery.
If you or a loved one has suffered from a heart attack or stroke following surgery please contact us for help in finding out if Trasyol (aprotinin) was used during the surgery. We can also go over your legal rights and options and evaluate any potential Trasylol claims you may have.
Trasylol studies, Aprotinin, Trasylol attorney, Open heart surgery, Trasylol lawsuit, Kidney failure, Heart attack, Stroke
We are a Law Firm that is dedicated to helping people who have been affected by Trasylol side effects.
Personal Injury Law Firm
Patients and families nationwide have looked at filing a Trasylol lawsuit based on the often fatal side effects of the drug Trasylol. Currently no Trasylol class action suits have been filed by Fields Law Firm and claims are being made individually.
The lawsuits claim that Bayer, the drug’s manufacturer, was negligent in several ways including:
• marketing [...]
The Trasylol heart surgery drug has increasingly been linked to serious side effects including kidney failure and stroke following bypass surgery. Many patients and families have questioned whether Bayer’s heart medication, also referred to as “Aprotinin“, was used during their procedure. The problem is that without looking at the medical records from the day of [...]
Bayer’s widely used Trasylol heart surgery drug was subject to a recall in 2007 following a study that raised safety concerns. Prior to the recall, Trasylol (also referred to as Aprotinin) was used to help prevent excessive bleeding during open heart surgery. The study reported that Bayer’s heart surgery medication increased the risk of dying [...]
Following a Trasylol recall in 2007, Bayer’s heart surgery drug continued to be used during heart surgery even though cheaper and safer alternative drugs were available. Unfortunately, Trasylol was used until as recently as May 2008.In 1993, Trasylol (also referred to as “aprotinin”) received FDA approval for use in certain types of heart surgeries. Until [...]
Bayer’s problems are growing as they face thousands of potential Trasylol lawsuits following increasing reports of their heart surgery drug’s side effects. Trasylol has recently been linked to a higher risk of kidney failure, heart attack, and death in the five years following a patient undergoing bypass heart surgery. In 1993 Trasylol (Aprotinin) was approved [...]